New anti-HIV drugs in development., in Proj Inf Perspect, n. 28, Sep 1999, pp. 4-8, PMID 11367365.
JT. Schouten, Protease inhibitors., in STEP Perspect, vol. 7, n. 3, 1995, pp. 12-3, PMID 11362981.
N. Tachikawa, [Protease inhibitors]., in Kansenshogaku Zasshi, vol. 79, n. 12, Dec 2005, pp. 905-30, PMID 16444973.
S. Vella, Update on HIV protease inhibitors., in AIDS Clin Care, vol. 7, n. 10, Oct 1995, pp. 79-82, 88, PMID 11362832.
HL. Sham, DJ. Kempf; A. Molla; KC. Marsh; GN. Kumar; CM. Chen; W. Kati; K. Stewart; R. Lal; A. Hsu; D. Betebenner, ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease., in Antimicrob Agents Chemother, vol. 42, n. 12, Dec 1998, pp. 3218-24, PMID 9835517.
EM. Mangum, KK. Graham, Lopinavir-Ritonavir: a new protease inhibitor., in Pharmacotherapy, vol. 21, n. 11, Nov 2001, pp. 1352-63, PMID 11714208.
RP. van Heeswijk, A. Veldkamp; JW. Mulder; PL. Meenhorst; JM. Lange; JH. Beijnen; RM. Hoetelmans, Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience., in Antivir Ther, vol. 6, n. 4, Dec 2001, pp. 201-29, PMID 11878403.